evenfolioETF Details
First Trust·Health·FTXH · Nasdaq
First Trust Nasdaq Pharmaceuticals ETF (FTXH)
- Price
- $44.24
- —30 Oct 2026
- Assets
- $1.1B
- Total net assets
- Expense ratio
- 0.60%
- Category 1.00%
- Yield
- 0.70%
- Trailing distributions
- 1Y return
- 49.1%+20.2%
- Category 28.8%
- 3Y CAGR
- 24.3%+2.8%
- Category 21.5%
- 5Y CAGR
- 12.6%+8.4%
- Category 4.1%
Loading NAV history…
First Trust Nasdaq Pharmaceuticals ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | +6.7% | +13.8% | +31.2% | +34.9% | +49.1% | +24.3% | +12.6% | +10.1% | +9.3% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | +3.1% | +3.9% | +8.2% | +14.5% | +20.2% | +2.8% | +8.4% | -0.7% | -2.4% |
Holdings
The 10 largest positions make up 54.0% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| ABBV | AbbVie Inc | 7.30% |
| PFE | Pfizer Inc | 7.17% |
| LLY | Eli Lilly and Co | 7.16% |
| JNJ | Johnson & Johnson | 7.13% |
| MRK | Merck & Co Inc | 7.04% |
| VTRS | Viatris Inc | 3.84% |
| BIIB | Biogen Inc | 3.73% |
| GILD | Gilead Sciences Inc | 3.64% |
| AMGN | Amgen Inc | 3.51% |
| INCY | Incyte Corp | 3.48% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- 26.0
- P/B
- 4.5
- P/S
- 4.7
- P/CF
- 16.6
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks99.9%
- Cash0.1%
ETF details
- Issuer
- First Trust
- Category
- Equity · Health
- Ticker
- FTXH
- Exchange
- Nasdaq
- Inception
- 20 Sept 2016 (10.1 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.60% (category 1.00%)
- Holdings turnover
- 35% (category 51%)
- Distribution yield
- 0.70%
- Beta, 3 years
- 0.43
- Total net assets
- $1.1B
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- PBPH · Portfolio Building Block World Pharma and Biotech Index ETFPortfolio Building Block ETFs · $1B · ER 0.13%
- PPH · VanEck Pharmaceutical ETFVanEck · $1B · ER 0.36%5Y 11.8%
- RSPH · Invesco S&P 500 Equal Weight Health Care ETFInvesco · $882.1M · ER 0.40%5Y 5.9%
- PJP · Invesco Pharmaceuticals ETFInvesco · $557.2M · ER 0.58%5Y 11.7%
- XPH · State Street SPDR S&P Pharmaceuticals ETFState Street Investment Management · $524M · ER 0.35%5Y 7.5%
- BBH · VanEck Biotech ETFVanEck · $487.7M · ER 0.35%5Y 5.8%